Ophthalmology & Visual Sciences

Vinit Mahajan, MD, PhD

Portrait

Mailing Address

Office: 11196D PFP
Iowa City, IA 52242
Phone: +1 319 356 8161
Email: vinit-mahajan@uiowa.edu

Web: Mahajan Labs

Education

BA, Molecular and Cell Biology, University of California, Berkeley, 1992
MD, NIH Medical Scientist Training Program, University of California, Irvine, 2001
PhD, NIH Medical Scientist Training Program, University of California, Irvine, 2001
Internship, Transitional (Surgical-Medicine), Harbor-UCLA Medical Center, Torrence, 2002
Residency, Ophthalmology, EyeSTAR Fellow, Jules Stein Eye Institute, University of California Los Angeles, 2006
Fellowship, Vitreoretinal Diseases and Surgery, University of Iowa, 2008

Appointments

Primary: Ophthalmology & Visual Sciences

Research Interests

diabetic retinopathy, macular degeneration, maculopathy, molecular genetic therapeutics, vitrectomy, gene therapy

Research Summary

My career goal is to understand and discover new treatments for vitreoretinal disease. My passion and core belief is that the delivery of molecular genetic therapeutics for vitreoretinal disease can be accelerated into the clinic and operating room by translational research teams of clinicians and scientists.

Publications

  • Skeie, J, Tsang, S, Mahajan, V. Evisceration of mouse vitreous and retina for proteomic analyses. J Vis Exp null(50):null, 2011. [PubMed]
  • Skeie, J, Mahajan, V. Dissection of human vitreous body elements for proteomic analysis. J Vis Exp null(47):null, 2011. [PubMed]
  • Kay, C, Tarantola, R, Gehrs, K, Folk, J, Mahajan, V, Boldt, H, Syed, N, Russell, S. Uveitis following intravitreal bevacizumab: a non-infectious cluster. Ophthalmic Surg Lasers Imaging 42(4):292-6, 0. [PubMed]
  • Roller, A, Folk, J, Patel, N, Boldt, H, Russell, S, Abramoff, M, Mahajan, V. Intravitreal bevacizumab for treatment of proliferative and nonproliferative type 2 idiopathic macular telangiectasia. Retina 31(9):1848-55, 2011. [PubMed]
  • Mahajan, V, Tarantola, R, Graff, J, Boldt, H, Abramoff, M, Russell, S, Folk, J. Sutureless triplanar sclerotomy for 23-gauge vitrectomy. Arch Ophthalmol 129(5):585-90, 2011. [PubMed]
  • Ko, A, Brinton, J, Mahajan, V, Zimmerman, B, Brinton, G, Stone, E, Folk, J, Mullins, R. Seroreactivity against aqueous-soluble and detergent-soluble retinal proteins in posterior uveitis. Arch Ophthalmol 129(4):415-20, 2011. [PubMed]
  • Tarantola, R, Folk, J, Shah, S, Boldt, H, Abràmoff, M, Russell, S, Mahajan, V. Intraoperative choroidal detachment during 23-gauge vitrectomy. Retina 31(5):893-901, 2011. [PubMed]
  • Mahajan, V, Elkins, K, Russell, S, Boldt, H, Gehrs, K, Weingeist, T, Stone, E, Abràmoff, M, Liu, D, Folk, J. Bilateral intravitreal injection of antivascular endothelial growth factor therapy. Retina 31(1):31-5, 2011. [PubMed]
  • Tao, H, Manak, J, Sowers, L, Mei, X, Kiyonari, H, Abe, T, Dahdaleh, N, Yang, T, Wu, S, Chen, S, Fox, M, Gurnett, C, Montine, T, Bird, T, Shaffer, L, Rosenfeld, J, McConnell, J, Madan-Khetarpal, S, Berry-Kravis, E, Griesbach, H, Saneto, R, Scott, M, Antic, D, Reed, J, Boland, R, Ehaideb, S, El-Shanti, H, Mahajan, V, Ferguson, P, Axelrod, J, Lehesjoki, A, Fritzsch, B, Slusarski, D, Wemmie, J, Ueno, N, Bassuk, A. Mutations in prickle orthologs cause seizures in flies, mice, and humans. Am J Hum Genet 88(2):138-49, 2011. [PubMed]
  • Tarantola, R, Folk, J, Boldt, H, Mahajan, V. Intravitreal bevacizumab during pregnancy. Retina 30(9):1405-11, 2010. [PubMed]